Navigation Links
Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition

Simulation-based program helps healthcare providers build competence and confidence while keeping infections at bay

DENVER, May 11 /PRNewswire/ -- Medical Simulation Corporation (MSC) will launch the SimSuite Central Line Management Program at AACN's National Teaching Institute (NTI) and Critical Care Exposition, the world's largest conference for nurses who care for acutely and critically ill patients, May 16-21, in New Orleans, LA. The Central Line Management Program is the latest offering in a full menu of MSC simulation-based curriculum that address national initiatives led by organizations, such as the Institute for Healthcare Improvement, Joint Commission, Leapfrog, CDC and Medicare, to track and improve patient safety and quality in the hospital setting.

Each year, an estimated 250,000 cases of central line-associated bloodstream infections (CLABSI) occur in hospitals in the United States. These potentially preventable infections are associated with an estimated mortality of 12 to 25 percent and an additional cost up to $56,000 per episode. MSC's comprehensive SimSuite Central Line Management Program brings together the best practices for central venous catheter insertion and management into a comprehensive program that increases the competence and confidence(R) of all healthcare team members.

"The SimSuite Central Line Management Program provides information on incidence, prevalence, epidemiology, and direct and indirect costs associated with central line associated bloodstream infections," says Julibeth Petter, PhD, ACNS-BC, ANCC Board Certified Clinical Nurse Specialist and SimSuite Central Line Management Program Author. "Providing this level of detail increases learners' understanding and motivates them to standardize and achieve best practices for their patients."

The SimSuite Central Line Management Program includes a web-based course and two types of simulation that bring together national guidelines for CLABSI prevention and safe central line insertion practices in a dynamic and hands-on training format. Patient care scenarios presented on a human patient simulator allow participants to practice managing patients with central lines and recognizing complications associated with central lines. The skills simulation allows physicians and providers to practice central venous access using SonoSite(R) ultrasound technology and a central venous trainer. MSC has selected SonoSite, Inc. as its preferred ultrasound vendor for the SimSuite Central Line Management Program.

Benefits of the program for nurses and providers include documentation of competence and compliance, standardized training across all team members, integration of best practices into quality improvement programs and team training.

"Procedures such as central line placement occur in a team; therefore, the best learning environment should occur in a team. The SimSuite Central Line Management Program allows healthcare providers to improve their teamwork skills as they work in their individual roles, and have the opportunity to swap roles," says Dr. Petter.

The Central Line Management Program will be presented at the MSC Booth (#1951) during the NTI Critical Care Exposition, May 19-21, with opportunities for all NTI attendees to participate in both types of simulation. More information about the program, including training options, will be available at NTI and can also be found online at

About Medical Simulation Corporation

Medical Simulation Corporation (MSC) is the recognized healthcare industry leader in providing full-service simulation training and education services to healthcare personnel, medical societies and medical product manufacturers. MSC's patient safety solutions are designed to strengthen the competence and confidence of nurses, physicians and technologists. Through its network of training platforms, MSC can provide customized training services to any location worldwide. For more information, please visit or call 888/889-5882.

SOURCE Medical Simulation Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... San Francisco, CA (PRWEB) , ... November 25, ... ... leading microbial genomics company uBiome, were featured on AngelList early in their initial ... by launching an AngelList syndicate for individuals looking to make early stage investments ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:10/29/2015)...  The J. Craig Venter Institute (JCVI) policy group ... Biosecurity: Lessons Learned and Options for the Future," which ... Services guidance for synthetic biology providers has worked since ... --> --> Synthetic biology promises great ... pose unique biosecurity threats. It now is easier than ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
(Date:10/26/2015)... and LAS VEGAS , Oct. 26, ... , an innovator in modern authentication and a founding ... the launch of its latest version of the Nok ... organizations to use standards-based authentication that supports existing and ... Authentication Suite is ideal for organizations deploying customer-facing applications ...
Breaking Biology News(10 mins):